Introduction
The IMPROVE bleeding risk score was designed to estimate the risk of bleeding in acutely ill hospitalised patients in whom anticoagulation is being considered.
:
The IMPROVE bleeding risk score was designed to estimate the risk of bleeding in acutely ill hospitalised patients in whom anticoagulation is being considered.
EMBOLUS - THE APP
CONTACT US
SITE MAP
PRIVACY POLICY
NOTE: Whilst we have done our utmost to ensure the accuracy of the data in this section, users should access the original publications.
All information contained in this section of Practical-Haemostasis.com is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease.
The user of Practical-Haemostasis.com, assumes sole responsibility for any decisions made or actions taken based on the information contained herein.
1. Decousus H, Tapson VF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011; 139: 69-79.
2.
Hostler DC, Marx ES, et al. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score. Chest. 2016; 149: 372-9.
3.
Rosenberg DJ, Press A, et al. External validation of the IMPROVE Bleeding Risk Assessment Model in medical patients. Thromb Haemost. 2016; 116: 530-6.
4. Schunemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198-225
5. Djulbegovic B, Boylan A, Kolo S, et al. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis. Blood Adv. 2024;8(12):3214-24.
Site Design: Sang Medicine Ltd
Updated:
16-Dec-2024